Blood protein predictors of brain amyloid for enrichment in clinical trials? - Wikidata - wikimedia - TriplyDB

Blood protein predictors of brain amyloid for enrichment in clinical trials?

Blood protein predictors of brain amyloid for enrichment in clinical trials?

http://www.wikidata.org/entity/Q36926754

about

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins Nonvascular retinal imaging markers of preclinical Alzheimer's disease.Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.Detection of Alzheimer's Disease Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias

P2860

Q26774743-5C142380-55A7-49E6-B34B-1B088311FF55 Q29994562-6FAED49A-E47F-4B22-BD1A-03548CAF7398 Q37044150-2AD4795F-5584-4B0D-B876-907246366611 Q37347834-57F74C5C-79C9-48BB-9C4F-4866F5887A51 Q37363628-A13DC88A-FB18-4679-8ADC-2225F2308F56 Q38741096-7724D5E5-D573-47FB-B17D-A8AD9D7C375E Q39217840-35C26B00-AEED-4891-B48B-4155465738C4 Q42026115-25784452-7158-46B3-8DF4-4DD50DD52684 Q47200597-5EA53FA2-E23D-4BE1-81DD-41C6D69A66E7 Q50221800-E446C31F-AA76-4B79-B547-839C0021FE96 Q51760901-9024E8C2-9228-4931-8A15-750EA7FE2C1F Q58706105-98EDB640-7CD4-4F7B-B55A-7691351421B1 Q58779295-9D21F6AD-C0D5-4B73-AC42-899E2FB655B4

P2860

Blood protein predictors of brain amyloid for enrichment in clinical trials?

http://www.wikidata.org/entity/Q36926754

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Blood protein predictors of brain amyloid for enrichment in clinical trials?

@en

type

label

Blood protein predictors of brain amyloid for enrichment in clinical trials?

@en

prefLabel

Blood protein predictors of brain amyloid for enrichment in clinical trials?

@en

P1433

Q36926754-0A8EFBAB-D3D4-4704-BE52-B45E4726BE94

P1476

Q36926754-2F213E86-30CD-4C97-A4B7-D5C721D1734A

P2093

Q36926754-0731EE3F-4D7B-43C1-9FCA-77A2D25F0DD1

Q36926754-3DB0DD6A-E1E0-41DF-B0BF-1D6D2F858DAF

Q36926754-40DFD1DA-699E-4F85-83EB-37D3F397B126

Q36926754-49A3CDD2-73B1-4E83-9670-07C08EA541BE

Q36926754-5F8DD814-7A6F-4550-9A7D-B4C856C78D38

Q36926754-7D06CEFD-ACA5-48BB-BCD8-3EE8C66453E9

Q36926754-82E1097E-BA03-4731-B2B4-44EC9AB1AE19

Q36926754-8AEC28B9-6B8F-40FB-B69B-817168C2637F

Q36926754-BBF2774B-17F7-4A13-8F50-A9F7F268074C

Q36926754-BE1E66F2-FE85-474F-8703-6178C460EBEC

P2860

Q36926754-015E94C6-8213-4433-B799-964EDF860A89

Q36926754-08A36A1E-0F4E-4BE6-854A-A8F0B98C80FE

Q36926754-121154E3-4C63-4CD3-887B-4E6133EE8A3B

Q36926754-13C6F2AA-FB6B-4341-9B28-356399EAC797

Q36926754-170D358F-FCE4-4DC5-9FF7-7C6C52E535DF

Q36926754-1BB9AEBF-CADC-4AC9-9D74-9BE0377BBB2A

Q36926754-1E952F62-707B-4354-8F54-8EE743374900

Q36926754-2254845F-7212-4520-9227-EAA280B122AA

Q36926754-22645907-4F19-4B23-AFEF-B39BC7AC92EC

Q36926754-27962E75-F48D-44F5-9857-8C56A05BC3A7

P304

Q36926754-BFBC59D2-1ADA-4108-81AA-6231275518B5

P31

Q36926754-9DD0F645-8569-4618-BBDA-7978DA93B30C

P356

Q36926754-A2698F96-227C-409E-8FC1-2C2BF7E02C4B

P433

Q36926754-02BDB035-432B-4C5C-87F8-D8F42C98992F

P478

Q36926754-20A38F20-BFB4-4084-8468-8F4557B84F40

P50

Q36926754-08209B6F-D822-4D8E-A148-5A4FC03FD4FB

Q36926754-230268AE-6AC9-404C-9C75-039E17828D68

Q36926754-29D1F24B-5028-4D14-AA6F-35D2751DDC80

Q36926754-36462572-FB9F-4F9B-85A1-9D0330498408

Q36926754-371FE200-7FF4-45FC-865F-65CF562F8F5C

Q36926754-39A538FD-BC88-45BF-AE40-6A48AB407A94

Q36926754-9FC933D5-087D-452E-A34F-B96412F797A9

Q36926754-C6139DA8-FC0D-47BC-B601-4C44963852CE

Q36926754-F08B198F-8BF1-4F64-8DE9-8B035A99CE0E

P577

Q36926754-313BCF20-DB46-452F-8D2A-B66C9715E9A1

P5875

Q36926754-3F250A5D-4388-446D-8CA8-D338D5440551

P698

Q36926754-EFC81711-635D-45AF-B606-B6422A0C2DF0

P932

Q36926754-92880571-ADCC-4140-A1A3-8B789C034A8A

P356

J.DADM.2014.11.005

P1433

Alzheimer's & dementia (Amsterdam, Netherlands)

P1476

Blood protein predictors of brain amyloid for enrichment in clinical trials?

@en

P2093

AIBL Research Group

http://www.w3.org/2001/XMLSchema#string

Alison L Baird

http://www.w3.org/2001/XMLSchema#string

Andrew Torres

http://www.w3.org/2001/XMLSchema#string

Antonia Covin

http://www.w3.org/2001/XMLSchema#string

Chantal Bazenet

http://www.w3.org/2001/XMLSchema#string

Cristina Tan Hehir

http://www.w3.org/2001/XMLSchema#string

David Baker

http://www.w3.org/2001/XMLSchema#string

Howard J Rosen

http://www.w3.org/2001/XMLSchema#string

John Graf

http://www.w3.org/2001/XMLSchema#string

Karyuan Vivian Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Clearance of amyloid-beta by circulating lipoprotein receptors

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Plasma biomarkers of brain atrophy in Alzheimer's disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Interleukin-6, age, and corpus callosum integrity.

P304

48-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DADM.2014.11.005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Steven J Kiddle

Bruce L. Miller

Nicholas J Ashton

Gil D Rabinovici

P577

2015-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277610648

http://www.w3.org/2001/XMLSchema#string

P698

27239491

http://www.w3.org/2001/XMLSchema#string

P932

4876903

http://www.w3.org/2001/XMLSchema#string